FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026604013> ?p ?o ?g. }

• W2026604013 endingPage "959.e1" @default.
• W2026604013 startingPage "948" @default.
• W2026604013 abstract "In this study, we aimed to expand on our prior research into the relative efficacy of combining parent training, stimulant medication, and placebo (Basic therapy) versus parent training, stimulant, and risperidone (Augmented therapy) by examining treatment effects for attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), and conduct disorder (CD) symptoms and peer aggression, symptom-induced impairment, and informant discrepancy.Children (6-12 years of age; N = 168) with severe physical aggression, ADHD, and co-occurring ODD/CD received an open trial of parent training and stimulant medication for 3 weeks. Participants failing to show optimal clinical response were randomly assigned to Basic or Augmented therapy for an additional 6 weeks.Compared with Basic therapy, children receiving Augmented therapy experienced greater reduction in parent-rated ODD severity (p = .002, Cohen's d = 0.27) and peer aggression (p = .02, Cohen's d = 0.32) but not ADHD or CD symptoms. Fewer children receiving Augmented (16%) than Basic (40%) therapy were rated by their parents as impaired by ODD symptoms at week 9/endpoint (p = .008). Teacher ratings indicated greater reduction in ADHD severity (p = .02, Cohen's d = 0.61) with Augmented therapy, but not for ODD or CD symptoms or peer aggression. Although both interventions were associated with marked symptom reduction, a relatively large percentage of children were rated as impaired for at least 1 targeted disorder at week 9/endpoint by parents (Basic 47%; Augmented 27%) and teachers (Basic 48%; Augmented 38%).Augmented therapy was superior to Basic therapy in reducing severity of ADHD and ODD symptoms, peer aggression, and symptom-induced impairment, but clinical improvement was generally context specific, and effect sizes ranged from small to moderate. Clinical trial registration information-Treatment of Severe Childhood Aggression (The TOSCA Study); http://clinicaltrials.gov/; NCT00796302." @default.
• W2026604013 created "2016-06-24" @default.
• W2026604013 creator A5000585575 @default.
• W2026604013 creator A5003135433 @default.
• W2026604013 creator A5009585057 @default.
• W2026604013 creator A5011948151 @default.
• W2026604013 creator A5015388521 @default.
• W2026604013 creator A5032518803 @default.
• W2026604013 creator A5035236451 @default.
• W2026604013 creator A5037364414 @default.
• W2026604013 creator A5038086394 @default.
• W2026604013 creator A5041630323 @default.
• W2026604013 creator A5042787535 @default.
• W2026604013 creator A5042947456 @default.
• W2026604013 creator A5046341093 @default.
• W2026604013 creator A5048500503 @default.
• W2026604013 creator A5057846005 @default.
• W2026604013 creator A5064909248 @default.
• W2026604013 creator A5069598980 @default.
• W2026604013 creator A5078168361 @default.
• W2026604013 creator A5083864774 @default.
• W2026604013 creator A5087975138 @default.
• W2026604013 creator A5087993762 @default.
• W2026604013 creator A5088965802 @default.
• W2026604013 date "2014-09-01" @default.
• W2026604013 modified "2023-10-15" @default.
• W2026604013 title "Risperidone Added to Parent Training and Stimulant Medication: Effects on Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct Disorder, and Peer Aggression" @default.
• W2026604013 cites W1964957356 @default.
• W2026604013 cites W1968430210 @default.
• W2026604013 cites W1969570897 @default.
• W2026604013 cites W1976881402 @default.
• W2026604013 cites W1983302342 @default.
• W2026604013 cites W1984246160 @default.
• W2026604013 cites W1989968363 @default.
• W2026604013 cites W1991549050 @default.
• W2026604013 cites W2009964820 @default.
• W2026604013 cites W2013051231 @default.
• W2026604013 cites W2013167152 @default.
• W2026604013 cites W2014360912 @default.
• W2026604013 cites W2018949073 @default.
• W2026604013 cites W2021155799 @default.
• W2026604013 cites W2033679013 @default.
• W2026604013 cites W2040554423 @default.
• W2026604013 cites W2063648119 @default.
• W2026604013 cites W2064139332 @default.
• W2026604013 cites W2064396657 @default.
• W2026604013 cites W2069778931 @default.
• W2026604013 cites W2071199156 @default.
• W2026604013 cites W2079013226 @default.
• W2026604013 cites W2085955598 @default.
• W2026604013 cites W2088387834 @default.
• W2026604013 cites W2095775564 @default.
• W2026604013 cites W2106249983 @default.
• W2026604013 cites W2124093756 @default.
• W2026604013 cites W2130411411 @default.
• W2026604013 cites W2133752375 @default.
• W2026604013 cites W2144456051 @default.
• W2026604013 cites W2410111223 @default.
• W2026604013 doi "https://doi.org/10.1016/j.jaac.2014.05.008" @default.
• W2026604013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4145805" @default.
• W2026604013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25151418" @default.
• W2026604013 hasPublicationYear "2014" @default.
• W2026604013 type Work @default.
• W2026604013 sameAs 2026604013 @default.
• W2026604013 citedByCount "60" @default.
• W2026604013 countsByYear W20266040132014 @default.
• W2026604013 countsByYear W20266040132015 @default.
• W2026604013 countsByYear W20266040132016 @default.
• W2026604013 countsByYear W20266040132017 @default.
• W2026604013 countsByYear W20266040132018 @default.
• W2026604013 countsByYear W20266040132019 @default.
• W2026604013 countsByYear W20266040132020 @default.
• W2026604013 countsByYear W20266040132021 @default.
• W2026604013 countsByYear W20266040132022 @default.
• W2026604013 countsByYear W20266040132023 @default.
• W2026604013 crossrefType "journal-article" @default.
• W2026604013 hasAuthorship W2026604013A5000585575 @default.
• W2026604013 hasAuthorship W2026604013A5003135433 @default.
• W2026604013 hasAuthorship W2026604013A5009585057 @default.
• W2026604013 hasAuthorship W2026604013A5011948151 @default.
• W2026604013 hasAuthorship W2026604013A5015388521 @default.
• W2026604013 hasAuthorship W2026604013A5032518803 @default.
• W2026604013 hasAuthorship W2026604013A5035236451 @default.
• W2026604013 hasAuthorship W2026604013A5037364414 @default.
• W2026604013 hasAuthorship W2026604013A5038086394 @default.
• W2026604013 hasAuthorship W2026604013A5041630323 @default.
• W2026604013 hasAuthorship W2026604013A5042787535 @default.
• W2026604013 hasAuthorship W2026604013A5042947456 @default.
• W2026604013 hasAuthorship W2026604013A5046341093 @default.
• W2026604013 hasAuthorship W2026604013A5048500503 @default.
• W2026604013 hasAuthorship W2026604013A5057846005 @default.
• W2026604013 hasAuthorship W2026604013A5064909248 @default.
• W2026604013 hasAuthorship W2026604013A5069598980 @default.
• W2026604013 hasAuthorship W2026604013A5078168361 @default.
• W2026604013 hasAuthorship W2026604013A5083864774 @default.
• W2026604013 hasAuthorship W2026604013A5087975138 @default.
• W2026604013 hasAuthorship W2026604013A5087993762 @default.
• W2026604013 hasAuthorship W2026604013A5088965802 @default.

• next